Rare Diseases in India: Families Struggle with High Treatment Costs and Limited Access

Patients living with rare diseases in India are facing immense financial, medical, and emotional challenges, as high treatment costs and limited access to specialized therapies place a heavy burden on families, according to a report by the entity ["organization", "India Today", "Indian news"] magazine.

Rare diseases, though individually uncommon, collectively affect treatment, specialized medication, or advanced therapies that are often expensive and not widely available.

High Cost of Treatment:

Experts say that treatments for rare genetic or metabolic disorders can cost lakhs—and sometimes crores—of rupees annually. For many families, this translates into exhausting savings, taking loans, or relying on crowdfunding to afford essential care.

Some advanced therapies, including enzyme replacement treatments and gene-based interventions, remain financially out of reach without government assistance or insurance coverage.

Delayed Diagnosis and Limited Awareness

Patients often experience delays in diagnosis due to limited awareness and inadequate screening infrastructure. Early detection is critical for managing many rare conditions, but access to specialized testing centers remains uneven across regions.

Medical professionals stress the importance of expanding genetic testing facilities and training healthcare providers to recognize symptoms earlier.

Policy and Support Measures:

The government has introduced frameworks aimed at addressing rare diseases, including financial assistance programs for eligible patients. However, implementation challenges and funding limitations persist.

Advocacy groups are calling for stronger insurance coverage, improved drug accessibility, and greater investment in domestic research and development.

Living with Uncertainty

For many families, managing a rare disease means navigating uncertainty, frequent hospital visits, and long-term care planning. Experts argue that a comprehensive approach—combining policy reform, public awareness, and healthcare infrastructure expansion—is essential to improve outcomes.

The report underscores the urgent need for systemic solutions to reduce the burden on patients and ensure equitable access to life-saving treatments.